Abstract
In a retrospective study the records of 34 consecutive cases with tumors metastatic to the orbit were reviewed with special attention to the management and prognosis of these patients. The primary tumor site was the breast in 20 patients, prostate in 5, kidney in 2 and skin in 2. The remaining 5 patients had other primary tumour sites. The symptoms of orbital metastasis preceded the detection of the primary tumor in 8 cases (24%). Twenty patients died after a mean interval of 25 months following the diagnosis of the orbital metastasis. This study gives a summary of the clinical features of these patients. With improved methods of treatment it was possible to obtain a relief of orbital symptoms in 24 patients (71%). Although the life expectancy of these patients remains poor, treatment can result in symptomatic relief and in an improvement in the quality of life, which is the main goal in the management of these patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bullock JD, Yanes B (1980) Ophthalmic manifestations of metastatic breast cancer. Ophthalmology 87:961–973
Bullock JD, Yanes B (1980) Metastatic tumors of the orbit. Ann Ophthalmol 12:1392–1394
Canellos GP, DeVita VT, Gold GP, Chabner BA, Schein PS, Young RC (1976) Combination chemotherapy for advanced breast cancer: response and effect on survival. Ann Intern Med 84:389–392
Capone A, Slamovits TL (1990) Discrete metastasis of solid tumors to extraocular muscles. Arch Ophthalmol 108:237–243
Cavalli F, Beer M, Martz G, Jungi WF, Alberto P, Obrecht JP, Mermillod B (1983) Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: report of the Swiss group for clinical cancer research. Br Med J 286:5–8
Ekman P, Snochowski M, Zetterberg A, Högberg B, Gustafsson J (1979) Steroid receptor content in human prostatic carcinoma and response to endocrine therapy. Cancer 44:1173–1181
Font RL, Ferry AP (1976) Carcinoma metastatic to the eye and orbit. III. A clinicopathologic study 28 cases metastatic to the orbit. Cancer 38:1326–1335
Glassburn JR, Klionsky M, Brady LW (1984) Radiation therapy for metastatic disease involving the orbit. Am J Clin Oncology 7:145–148
Goldberg RA, Rootman J (1990) Clinical characteristics of metastatic orbital tumors. Ophthalmology 97:620–624
Goldberg RA, Rootman J, Cline RA (1990) Tumors metastatic to the orbit: a changing picture. Surv Ophthalmol 35:1–24
Heckemann R, Schmitt G (1978) Ergebnisse der Strahlentherapie metastatischer Orbitatumoren. Strahlentherapie 154:179–181
Henderson JW (1980) Metastatic carcinoma. In: Henderson JW (ed) Orbital tumors, 2nd edn. Decker, New York, pp 451–471
Huh SH, Nisce LZ, Simpson LD, Chu FCH (1974) Value of radiation therapy in the treatment of orbital metastasis. Am J Roentgenol Radium Ther Nucl Med 120:589–594
Jöbsis AC, De Vries GP, Anholt RRH, Sanders GTB (1978) Demonstration of the prostatic origin of metastases. An immunohistochemical method for formalin-fixed embedded tissue. Cancer 41:1788–1793
Kopelman JE, Shorr N (1987) A case of prostatic carcinoma to the orbit diagnosed by fine needle aspiration and immunoperoxidase staining for prostatic specific antigen. Ophthalmic Surg 18:599–603
Manni A, Santen R, Boucher A, Lipton A, Harvey H, White D, Simmonds M, Gordon R, Rohner T, Drago J, Wettlaufer J, Glode L (1986) Androgen priming and response to chemotherapy in advanced prostate cancer. Proc Soc Clin Oncol 5:96
Maxon HR, Thomas SR, Hertzberg VS, Kereiakes JG, Chen IW, Sperling MI, Saenger L (1983) Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 309:937–941
Nadji M, Tabei SZ, Castro A, Chu TM, Murphy GP, Wang MC, Morales AR (1981) Prostatic-Specific Antigen: an immunologic marker for prostatic neoplasms. Cancer 48:1229–1232
Nomura Y, Yamagata J, Takenaka K, Tashiro H (1980) Steroid hormone receptors and clinical usefulness in human breast cancer. Cancer 46:2990–2993
Orcutt JC, Char DH (1988) Melanoma metastatic to the orbit. Ophthalmology 95:1033–1037
Rootman J, Ragaz J, Cline R, Lapointe JS (1988) Orbital metastasis. In: Rootman J (ed) Diseases of the orbit. Lippincott, Philadelphia, pp 405–427
Rose AM (1965) Die Orbita als Absiedlungsort von Malignomen. Klin Monatsbl Augenheilkd 147:857–862
Rosenberg SA, Lotze AT, Muni LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson C, Reichert CM (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313:1485–1492
Shields CL, Shields JA, Peggs M (1988) Tumors metastatic to the orbit. Ophthalmic Plast Reconstr Surg 4:73–80
Shimaoka K, Schoenfeld DA, Lerner H, DeConti RC (1983) A randomized trial of adriamycine plus cis-diammine-dichloroplatinum in patients with thyroid carcinoma. Proc Am Soc Clin Oncology 2:168
Sobol S, Druck NS, Wolf M (1980) Palliative orbital decompression for metastatic melanoma to the orbit. Laryngoscope 90:329–333
Tijl JWM, Koornneef L (1991) Fine needle aspiration biopsy in orbital tumours. Br J Ophthalmol 75:491–492
Torti FM, Carter SK (1980) The chemotherapy of prostatic adenocarcinoma. Ann Intern Med 92:681–689
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tijl, J., Koornneef, L., Eijpe, A. et al. Metastatic tumors to the orbit — management and prognosis. Graefe's Arch Clin Exp Ophthalmol 230, 527–530 (1992). https://doi.org/10.1007/BF00181773
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00181773